A Multicenter, Randomized, Double-Blind, Parallel Group, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of 1% and 3% Topical MIinocycline Gel (HY01) in Patients With Papulopustular Rosacea
Phase of Trial: Phase II
Latest Information Update: 20 Dec 2017
At a glance
- Drugs Minocycline (Primary)
- Indications Rosacea
- Focus Therapeutic Use
- Acronyms MARS
- Sponsors Hovione
- 13 Dec 2017 Status changed from not yet recruiting to recruiting, according to a Hovione media release.
- 13 Dec 2017 According to a Hovione media release, this study will also include a cohort to determine minocycline systemic pharmacokinetic parameters, and completion of this study expected by the end of 2018.
- 13 Dec 2017 According to a Hovione media release, first patient has been enrolled.